The device is used during endovascular procedures, such as heart surgery, to detect and monitor bleeding.
Early Bird’s sheath – which keeps arteries and blood vessels open during cardiac and vascular surgeries – is covered in sensors that use a proprietary algorithm to measure electric resistance across the blood vessel. If an injury occurs and blood accumulates outside of the vessel, audio and visual notifications alert the medical team.
“Twenty-million patients in the United States undergo vascular access procedures each year, and approximately 1 million experience a severe bleeding complication,” Dr. Philippe Genereux, co-director of the Structural Heart Disease Program at Morristown Medical Center, said in a release.
In addition to added patient safety, the hospital pointed to a decrease in health care costs, complications from procedures and the length of hospital stays as benefits of the technology.
Early Bird Bleed Monitoring is currently available for investigational use only and has not yet been cleared by the U.S. Food and Drug Administration.